T. Rowe Price Associates’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $17.7M | Sell |
|
|||||
|
2025
Q2 | $22.7M | Buy |
|
|||||
|
2025
Q1 | $19M | Sell |
|
|||||
|
2024
Q4 | $56.6M | Sell |
|
|||||
|
2024
Q3 | $94.7M | Buy |
|
|||||
|
2024
Q2 | $83.5M | Buy |
|
|||||
|
2024
Q1 | $32.1M | Buy |
|
|||||
|
2023
Q4 | $180K | Sell |
|
|||||
|
2023
Q3 | $1.57M | Buy |
|
|||||
|
2023
Q2 | $124K | Sell |
|
|||||
|
2023
Q1 | $3.36M | Buy |
|
|||||
|
2022
Q4 | $453K | Buy |
|
|||||
|
2022
Q3 | $493K | Buy |
|
|||||
|
2022
Q2 | $251K | Buy |
|
|||||
|
2022
Q1 | $351K | Buy |
|
|||||
|
2021
Q4 | $425K | Sell |
|
|||||
|
2021
Q3 | $590K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $10.2M | Sell |
|
|||||
|
2020
Q3 | $9.92M | Buy |
|